Bridging The Patient Journey With Real-World Outcomes Using Tokenization

Explore the growing role of real-world data (RWD) and tokenization in enhancing clinical research and patient-centered evidence generation. As regulatory agencies increasingly accept real-world evidence (RWE) in support of therapeutic approvals, the ability to accurately link disparate data sources—without compromising patient privacy—has become essential.

Tokenization, the process of converting personally identifiable information (PII) into unique, non-identifying codes, is highlighted as a key enabler for connecting electronic health records (EHRs), clinical trial data, and claims datasets. By doing so, tokenization supports a range of clinical and operational objectives, including optimizing study design, supporting external control arms, reducing long-term follow-up burdens, and improving data generalizability and regulatory readiness. Verana Health’s experience tokenizing over 90 million patient records across multiple specialties illustrates the value of this approach. When combined with partner RWD, tokenization unlocks insights into disease progression, patient burden, safety outcomes, and healthcare utilization, particularly in rare and chronic diseases. Tokenization, especially when implemented early, can accelerate clinical development timelines, reduce costs, and ensure more complete, privacy-protected patient journeys. This foundational capability positions life science organizations to transform evidence generation across all phases of development.